Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 7682083, 9 pages
https://doi.org/10.1155/2017/7682083
Research Article

Progranulin Inhibits Human T Lymphocyte Proliferation by Inducing the Formation of Regulatory T Lymphocytes

Institute of Oral Biology, School of Dentistry, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea

Correspondence should be addressed to Hyeon-Woo Lee; rk.ca.uhk@oownoeyh

Received 12 October 2016; Revised 5 December 2016; Accepted 27 December 2016; Published 17 January 2017

Academic Editor: Jagadeesh Bayry

Copyright © 2017 Kyu Hwan Kwack and Hyeon-Woo Lee. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Sakaguchi, K. Wing, Y. Onishi, P. Prieto-Martin, and T. Yamaguchi, “Regulatory T cells: how do they suppress immune responses?” International Immunology, vol. 21, no. 10, pp. 1105–1111, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Sakaguchi, M. Miyara, C. M. Costantino, and D. A. Hafler, “FOXP3+ regulatory T cells in the human immune system,” Nature Reviews Immunology, vol. 10, no. 7, pp. 490–500, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Ouyang, O. Beckett, Q. Ma, and M. O. Li, “Transforming growth factor-β signaling curbs thymic negative selection promoting regulatory T cell development,” Immunity, vol. 32, no. 5, pp. 642–653, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Xu, A. Kitani, and W. Strober, “Molecular mechanisms regulating TGF-β-induced Foxp3 expression,” Mucosal Immunology, vol. 3, no. 3, pp. 230–238, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. Curotto de Lafaille and J. J. Lafaille, “Natural and adaptive Foxp3+ regulatory T cells: more of the same or a division of labor?” Immunity, vol. 30, no. 5, pp. 626–635, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Zhou, N. Kong, H. Zou et al., “Therapeutic potential of TGF-β-induced CD4+ Foxp3 + regulatory T cells in autoimmune diseases,” Autoimmunity, vol. 44, no. 1, pp. 43–50, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. E. M. Dons, G. Raimondi, D. K. C. Cooper, and A. W. Thomson, “Induced regulatory T cells: mechanisms of conversion and suppressive potential,” Human Immunology, vol. 73, no. 4, pp. 328–334, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. E. G. Schmitt and C. B. Williams, “Generation and function of induced regulatory T cells,” Frontiers in Immunology, vol. 4, article 152, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Zhou, G. Gao, J. W. Crabb, and G. Serrero, “Purification of an autocrine growth factor homologous with mouse epithelin precursor from a highly tumorigenic cell line,” Journal of Biological Chemistry, vol. 268, no. 15, pp. 10863–10869, 1993. View at Google Scholar · View at Scopus
  10. H. Zhang and G. Serrero, “Inhibition of tumorigenicity of the teratoma PC cell line by transfection with antisense cDNA for PC cell-derived growth factor (PCDGF, epithelin/granulin precursor),” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 24, pp. 14202–14207, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Van Damme, A. Van Hoecke, D. Lambrechts et al., “Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival,” The Journal of Cell Biology, vol. 181, no. 1, pp. 37–41, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Kessenbrock, L. Fröhlich, M. Sixt et al., “Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin,” The Journal of Clinical Investigation, vol. 118, no. 7, pp. 2438–2447, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Zhu, C. Nathan, W. Jin et al., “Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair,” Cell, vol. 111, no. 6, pp. 867–878, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Tolkatchev, S. Malik, A. Vinogradova et al., “Structure dissection of human progranulin identifies well-folded granulin/epithelin modules with unique functional activities,” Protein Science, vol. 17, no. 4, pp. 711–724, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Daniel, E. Daniels, Z. He, and A. Bateman, “Progranulin (acrogranin/PC cell-derived growth factor/granulin-epithelin precursor) is expressed in the placenta, epidermis, microvasculature, and brain during murine development,” Developmental Dynamics, vol. 227, no. 4, pp. 593–599, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. He and A. Bateman, “Progranulin gene expression regulates epithelial cell growth and promotes tumor growth in vivo,” Cancer Research, vol. 59, no. 13, pp. 3222–3229, 1999. View at Google Scholar · View at Scopus
  17. A. Bateman and H. P. J. Bennett, “The granulin gene family: from cancer to dementia,” BioEssays, vol. 31, no. 11, pp. 1245–1254, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Huang, C. Huang, K. Shan, J. Chen, and H. Li, “Significance of PC cell-derived growth factor and cyclin D1 expression in cutaneous squamous cell carcinoma,” Clinical and Experimental Dermatology, vol. 37, no. 4, pp. 411–417, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. He, C. H. P. Ong, J. Halper, and A. Bateman, “Progranulin is a mediator of the wound response,” Nature Medicine, vol. 9, no. 2, pp. 225–229, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Jian, J. Konopka, and C. Liu, “Insights into the role of progranulin in immunity, infection, and inflammation,” Journal of Leukocyte Biology, vol. 93, no. 2, pp. 199–208, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. I. D. Nagtegaal, E. A. J. F. Lakke, and E. Marani, “Trophic and tropic factors in the development of the central nervous system,” Archives of Physiology and Biochemistry, vol. 106, no. 3, pp. 161–202, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Kojima, K. Ono, K. Inoue et al., “Progranulin expression in advanced human atherosclerotic plaque,” Atherosclerosis, vol. 206, no. 1, pp. 102–108, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Matsubara, A. Mita, K. Minami et al., “PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue,” Cell Metabolism, vol. 15, no. 1, pp. 38–50, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Park, L. Buti, S. Lee et al., “Granulin is a soluble cofactor for toll-like receptor 9 signaling,” Immunity, vol. 34, no. 4, pp. 505–513, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. S. M. McIsaac, A. W. Stadnyk, and T.-J. Lin, “Toll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosis,” Journal of Leukocyte Biology, vol. 92, no. 5, pp. 977–985, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Tang, Y. Lu, Q.-Y. Tian et al., “The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice,” Science, vol. 332, no. 6028, pp. 478–484, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Wei, Y. Zhang, W. Zhao, X. Yu, and C.-J. Liu, “Progranulin facilitates conversion and function of regulatory T cells under inflammatory conditions,” PLoS ONE, vol. 9, no. 11, Article ID e112110, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Hu, T. Padukkavidana, C. B. Vægter et al., “Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin,” Neuron, vol. 68, no. 4, pp. 654–667, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Zheng, O. A. Brady, P. S. Meng, Y. Mao, and F. Hu, “C-terminus of progranulin interacts with the beta-propeller region of sortilin to regulate progranulin trafficking,” PLoS ONE, vol. 6, no. 6, Article ID e21023, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Zhou, L. Sun, F. B. de Oliveira et al., “Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin,” Journal of Cell Biology, vol. 210, no. 6, pp. 991–1002, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. X. Chen, J. Chang, Q. Deng et al., “Progranulin does not bind tumor necrosis factor (TNF) receptors and is not a direct regulator of TNF-dependent signaling or bioactivity in immune or neuronal cells,” The Journal of Neuroscience, vol. 33, no. 21, pp. 9202–9213, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. B. C. Wang, H. Liu, A. Talwar, and J. Jian, “New discovery rarely runs smooth: an update on progranulin/TNFR interactions,” Protein and Cell, vol. 6, no. 11, pp. 792–803, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Alquézar, A. de la Encarnación, F. Moreno, A. López de Munain, and Á. Martín-Requero, “Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers,” Journal of Psychiatry and Neuroscience, vol. 41, no. 4, pp. 225–239, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Wei, A. Hettinghouse, and C. Liu, “The role of progranulin in arthritis,” Annals of the New York Academy of Sciences, vol. 1383, no. 1, pp. 5–20, 2016. View at Publisher · View at Google Scholar